PALVELLA THERAPEUTICS, INC.
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
Dec-15 |
Dec-14 |
Dec-13 |
| Total revenue |
0.00 |
0.00 |
0.00 |
0.03 |
0.03 |
0.03 |
0.05 |
0.03 |
0.03 |
0.01 |
0.00 |
0.01 |
0.01 |
| Cost of revenue |
|
|
|
0.00 |
0.00 |
|
|
|
|
|
|
|
|
| Gross profit |
|
|
|
0.02 |
0.03 |
0.03 |
|
|
|
|
|
|
|
| Selling, general and administrative |
0.02 |
0.01 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
| Research and development |
0.02 |
0.01 |
0.01 |
0.05 |
0.06 |
0.04 |
0.05 |
0.04 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.01 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.00 |
| Operating income |
-0.04 |
-0.01 |
-0.01 |
-0.04 |
-0.05 |
-0.03 |
-0.03 |
-0.03 |
-0.01 |
-0.02 |
-0.01 |
-0.01 |
0.00 |
| Non-operating income (net) |
0.00 |
0.00 |
0.03 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.04 |
-0.02 |
0.02 |
-0.03 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
0.00 |
| Income tax expense |
|
|
|
0.00 |
|
0.00 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Net income |
-0.04 |
-0.02 |
0.02 |
-0.03 |
-0.05 |
-0.04 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
0.00 |
Show Quarterly Income Statement
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Sep-18 |
Jun-18 |
Mar-18 |
Dec-17 |
Sep-17 |
Jun-17 |
Mar-17 |
| Total revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.02 |
0.02 |
0.00 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.00 |
0.00 |
0.02 |
0.00 |
0.00 |
0.01 |
0.01 |
0.02 |
0.02 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.00 |
0.02 |
0.00 |
0.00 |
0.00 |
| Cost of revenue |
|
|
|
|
|
|
|
|
0.00 |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
|
0.00 |
0.00 |
0.00 |
| Gross profit |
|
|
|
|
|
|
|
|
|
0.00 |
0.02 |
0.02 |
0.00 |
0.01 |
0.00 |
0.00 |
0.01 |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
0.01 |
0.01 |
0.00 |
|
0.00 |
0.00 |
0.00 |
| Selling, general and administrative |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
0.01 |
-0.01 |
-0.01 |
-0.01 |
| Non-operating income (net) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.02 |
-0.02 |
0.00 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
0.01 |
-0.01 |
-0.01 |
-0.01 |
| Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
|
|
|
|
|
|
|
0.00 |
|
0.00 |
|
0.00 |
0.00 |
0.00 |
|
| Net income |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.02 |
-0.02 |
0.00 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
0.01 |
-0.01 |
-0.01 |
-0.01 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
Dec-15 |
Dec-14 |
Dec-13 |
| Cash and cash equivalents |
0.06 |
0.08 |
0.01 |
0.02 |
0.12 |
0.07 |
|
|
|
|
|
|
|
| Short-term investments |
|
|
|
0.02 |
|
|
|
|
|
|
|
|
|
| Accounts receivable, net |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
|
|
|
|
|
|
|
| Other current assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
|
|
|
|
|
|
|
| Total current assets |
0.06 |
0.09 |
0.01 |
0.02 |
0.13 |
0.08 |
|
|
|
|
|
|
|
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.06 |
0.09 |
0.01 |
0.02 |
0.15 |
0.11 |
|
|
|
|
|
|
|
|
| Accounts payable |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
|
|
|
|
|
|
|
| Short-term debt |
0.00 |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.01 |
0.01 |
0.00 |
0.00 |
0.02 |
0.01 |
|
|
|
|
|
|
|
| Long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital lease obligations |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
| Other non-current liabilities |
0.02 |
0.01 |
0.01 |
0.03 |
|
|
|
|
|
|
|
|
|
| Total liabilities |
0.03 |
0.03 |
0.01 |
0.04 |
0.10 |
0.07 |
|
|
|
|
|
|
|
|
| Common stock and paid-in capital |
0.16 |
0.16 |
0.07 |
0.07 |
0.31 |
0.24 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Retained earnings |
-0.14 |
-0.09 |
-0.08 |
-0.09 |
-0.26 |
-0.21 |
|
|
|
|
|
|
|
| Common shares outstanding |
11 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
Show Quarterly Balance Sheet
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Sep-18 |
Jun-18 |
Mar-18 |
Dec-17 |
Sep-17 |
Jun-17 |
Mar-17 |
| Cash and cash equivalents |
0.21 |
0.06 |
0.06 |
0.07 |
0.08 |
0.08 |
0.02 |
0.02 |
0.01 |
0.02 |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term investments |
0.06 |
|
|
|
|
|
|
|
|
0.01 |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accounts receivable, net |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other current assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total current assets |
0.26 |
0.06 |
0.07 |
0.07 |
0.08 |
0.09 |
0.02 |
0.03 |
0.01 |
0.04 |
0.06 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.26 |
0.06 |
0.07 |
0.07 |
0.08 |
0.09 |
0.02 |
0.03 |
0.01 |
0.04 |
0.06 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accounts payable |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term debt |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.00 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.00 |
0.01 |
0.00 |
0.01 |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital lease obligations |
0.00 |
0.00 |
|
|
|
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current liabilities |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total liabilities |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.03 |
0.00 |
0.01 |
0.01 |
0.01 |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock and paid-in capital |
0.38 |
0.16 |
0.16 |
0.16 |
0.16 |
0.16 |
0.34 |
0.34 |
0.07 |
0.34 |
0.34 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Retained earnings |
-0.15 |
-0.14 |
-0.12 |
-0.11 |
-0.10 |
-0.09 |
-0.33 |
-0.32 |
-0.08 |
-0.31 |
-0.31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common shares outstanding |
13 |
11 |
11 |
11 |
2 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
| Net income |
|
|
|
|
|
|
| Depreciation, depletion and amortization |
|
|
|
|
0.00 |
0.00 |
| Stock-based compensation |
0.01 |
0.00 |
0.00 |
0.00 |
|
|
| Change in inventory |
|
|
|
|
|
|
| Other working capital changes |
-0.03 |
-0.01 |
-0.01 |
-0.02 |
-0.01 |
-0.05 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.00 |
0.00 |
0.00 |
-0.02 |
0.00 |
0.04 |
| Dividend payout |
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
|
|
| Net Debt Issuance |
0.00 |
0.09 |
0.01 |
0.01 |
0.06 |
0.01 |
|
| Change in cash |
-0.03 |
0.08 |
-0.01 |
-0.03 |
0.05 |
0.00 |
Show Quarterly Cash Flow
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Mar-23 |
| Net income |
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
|
|
|
|
|
|
|
|
|
|
0.00 |
|
| Stock-based compensation |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
0.00 |
| Change in inventory |
|
|
|
|
|
|
|
|
|
|
|
|
| Other working capital changes |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
-0.02 |
-0.01 |
0.00 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
-0.06 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
|
|
| Net Debt Issuance |
0.21 |
0.00 |
0.00 |
0.00 |
0.00 |
0.07 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Change in cash |
0.15 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
0.07 |
0.00 |
0.01 |
0.00 |
-0.02 |
-0.01 |
0.00 |
PALVELLA THERAPEUTICS, INC. (PVLA) - Capital Lease Obligations
PALVELLA THERAPEUTICS, INC. (PVLA) - Total Non Current Liabilities
PALVELLA THERAPEUTICS, INC. (PVLA) - Short Term Debt
PALVELLA THERAPEUTICS, INC. (PVLA) - Current Accounts Payable
PALVELLA THERAPEUTICS, INC. (PVLA) - Total Current Liabilities
PALVELLA THERAPEUTICS, INC. (PVLA) - Total Liabilities
PALVELLA THERAPEUTICS, INC. (PVLA) - Other Current Assets
PALVELLA THERAPEUTICS, INC. (PVLA) - Total Non Current Assets
PALVELLA THERAPEUTICS, INC. (PVLA) - Current Net Receivables
PALVELLA THERAPEUTICS, INC. (PVLA) - Cash And Short Term Investments